Menu

Molecular Trigger for Organ Rejection in Mice Identified

The cell-surface receptor, SIRP-alpha, initiates the innate immune response in hosts.  

Jun 27, 2017
Diana Kwon

ISTOCK, TIRIPEROAround half of all organ transplants in humans are rejected by the recipient's immune system within 10 to 12 years. Scientists studying mice have now identified a key cell receptor that triggers this process. Their results were published last week (June 23) in Science Immunology.

"For the first time, we have an insight into the earliest steps that start the rejection response," study coauthor Fadi Lakkis of the University of Pittsburgh's Thomas E. Starzl Transplantation Institute, says in a statement. "Interrupting this first recognition of foreign tissues by the innate immune system would disrupt the rejection process at its earliest inception stage and could prevent the transplant from failing."

Using positional cloning, a method that can identify genetic mutations, Lakkis and colleagues discovered that SIRP-alpha, a cell-surface receptor that varies across individual mice, was responsible for activating the innate immune response—the body's first-line, nonspecific defense mechanism. When the researchers transplanted tissue from one mouse into a host animal with different SIRP-alpha receptors, the molecule bound to the CD47 receptor on the recipient's monocytes, a type of innate immune cell, and generated a rejection response.

Since human cells also express SIRP-alpha, sequencing this gene to identify donors with matching molecules could help reduce rejection rates, Lakkis says in the statement.

"One can imagine these interactions being critical in providing a constant trigger that poises the immune response to reject the organ, and thus new therapies that limit the function of these receptors may promote organ survival," Anita Chong, a professor of surgery at the University of Chicago who was not involved in the study, told the Pittsburgh Post-Gazette. "This is a possibility, although much work needs to be done to test whether this molecular pathway will actually impact the outcome of organ transplants in the clinic."

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!